Skip to product information
1 of 1

Human Platelet Lysate, Xeno Free

Human Platelet Lysate, Xeno Free

Cellarom Store

Request for Quote

Premium xeno-free Human Platelet Lysate solutions engineered for consistent cell culture expansion. Our hPL delivers superior growth factor concentrations while eliminating animal-derived components, reducing contamination risk, and ensuring regulatory compliance for clinical applications.

  • EliteGro™ and EliteGro™-Adv. are animal serum-free, xenogeneic-free cell culture supplements for research or commercial development of cell therapies. 
  • Successfully support cell proliferation of multiple types of mesenchymal stem cells without morphology or characterization change. 
  • Manufactured under cGMP compliant facility.
  • Available in 50 mL and 500 mL bottle packaging

Application

Supports the expansionof hMSCs and growth of human endoehelial cells and fibroblasts. Effective substitute for fetal bovine serum (FBS). No Heparin needed

Cell Type

hMSCs, NK, CIK, T cells

Storage

- 20C

Specification

  • 50ml bottle
  • GMP manufacturing
  • Doesn't require addition of heparin and does not contain any anticoagulant
  • US FDA MF (biologics Master File)
  • US FDA Reviewed for IND Approval
View full details

Request for Quote

Contact us for quote and additional information

Scale up from pilot to clinical trials and commercialization with expert guidance on media selection, regulatory compliance, and supply chain optimization from North America's cell culture specialists.

Empowering Cell Therapy Organizations to Innovate

Cellarom was born from a desire to bridge the gap between research and development, pilot production and commercialization. We recognized the challenge of balancing scientifically acceptable product performance with the need to reduce manufacturing costs to produce cost-effective therapies.

At Cellarom, we are dedicated to:

  • Bridging Product Development and Commercialization in Cell Therapy
  • Cost-Effective and High-Quality Cell Therapy raw materials and solutions
  • Capability for Scaling Up Cell Therapy Production